Evidence map›Paper›PMID 30274279›Full record

ArticleNanomaterials (Basel, Switzerland)2018

Inhibition of TRPV1 Channel Activity in Human CD4⁺ T Cells by Nanodiamond and Nanoplatinum Liquid, DPV576.

Mamdooh H Ghoneum, James K Gimzewski, Aya Ghoneum, Hideki Katano, Clarissa Nila Paw U, Anshu Agrawal

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Febrile temperature change modulates CD4 T cell differentiation via a TRPV channel-regulated Notch-dependent pathway.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Mamdooh H GhoneumDepartment of Surgery, Charles Drew University of Medicine and Science, Los Angeles, CA 90059, USA. mghoneum@ucla.edu.ORCID 0000-0002-1087-7127
James K GimzewskiDepartment of Chemistry and Biochemistry, UCLA, 607 Charles E. Young Drive East, Los Angeles, CA 90095, USA. gimzewski@cnsi.ucla.edu.
Aya GhoneumDepartment of Chemistry and Biochemistry, UCLA, 607 Charles E. Young Drive East, Los Angeles, CA 90095, USA. ayaghoneum@ucla.edu.
Hideki KatanoDepartment of Regenerative Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1143, Japan. katano@venex-j.co.jp.
Clarissa Nila Paw UDivision of Basic and Clinical Immunology, Department of Medicine, University of California, Irvine, CA 92697, USA. cpawu@uci.edu.
Anshu AgrawalDivision of Basic and Clinical Immunology, Department of Medicine, University of California, Irvine, CA 92697, USA. aagrawal@uci.edu.ORCID 0000-0002-3323-9152
University of California, Irvine · USCalifornia NanoSystems Institute · USCharles R. Drew University of Medicine and Science · USTokai University · JP

Funding

University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
NCATS NIH HHS UL1 TR001414
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

capsaicinCD4+ T cellsnanodiamondTRPV1

Identifiers

PMID30274279
PMCPMC6215208
OpenAlexW2894050447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.